Vimarsana
Biggest News Aggregation in the World

Page 39 - Published June News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Published June. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Published June Today - Breaking & Trending Today

S.A. Miller | Stories - Washington Times - Vimarsana News

S.A. Miller | Stories - Washington Times

Read the latest stories and columns from staff writer S.A. Miller in The Washington Times.

Machine-learning models help differentiate alcohol-associated hepatitis, acute cholangitis - Vimarsana News

Machine-learning models help differentiate alcohol-associated hepatitis, acute cholangitis

Alcohol-associated hepatitis and acute cholangitis were accurately diagnosed by machine-learning algorithms, which also outperformed physicians in distinguishing the two diseases, according to a study in Mayo Clinic Proceedings.“Our study is a proof of concept demonstrating how [machine-learning algorithms] using a few simple variables and routinely available structured clinical information

Source: healio.com
Atopic Dermatitis Biologics are Working, but Precision Care Remains a Goal - Vimarsana News

Atopic Dermatitis Biologics are Working, but Precision Care Remains a Goal

Diamant Thaci, MD, reviewed the state of real-world biologic therapy use for moderate to severe atopic dermatitis during a session at RAD 2023.

Survey for health care workers: Have you ever encountered macro or microaggressions? - Vimarsana News

Survey for health care workers: Have you ever encountered macro or microaggressions?

Physicians have created a survey for health care workers to assess experiences with microaggressions, sexism, racism and other forms of discrimination at work, school, in patient environments or during interactions with patients’ families.The survey, led by Shikha Jain, MD, FACP, an associate professor of medicine with tenure in the division of hematology, oncology and cell therapy at the

Source: healio.com
Tirzepatide Achieves Mean Weight Loss of 15.7% in SURMOUNT-2 Trial - Vimarsana News

Tirzepatide Achieves Mean Weight Loss of 15.7% in SURMOUNT-2 Trial

Data from the SURMOUNT-2 trial demonstrate use of tirzepatide 10 mg and 15 mg were associated with mean weight reductions of 13.4% and 15.7%, respectively, with more than 80% of tirzepatide users achieving a body weight reduction of 5% or greater.